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Abstract
Background: HIV-1 is frequently detected in the lungs of infected individuals and is likely important in the development of
pulmonary opportunistic infections. The unique environment of the lung, rich in alveolar macrophages and with specialized
local immune responses, may contribute to differential evolution or selection of HIV-1.
Methodology and Findings: We characterized HIV-1 in the lung in relation to contemporaneous viral populations in the
blood. The C2-V5 region of HIV-1 env was sequenced from paired lung (induced sputum or bronchoalveolar lavage) and
blood (plasma RNA and proviral DNA from sorted or unsorted PBMC) from 18 subjects. Compartmentalization between
tissue pairs was assessed using 5 established tree or distance-based methods, including permutation tests to determine
statistical significance. We found statistical evidence of compartmentalization between lung and blood in 10/18 subjects,
although lung and blood sequences were intermingled on phylogenetic trees in all subjects. The subject showing the
greatest compartmentalization contained many nearly identical sequences in BAL sample, suggesting clonal expansion may
contribute to reduced viral diversity in the lung in some cases. However, HIV-1 sequences in lung were not more
homogeneous overall, nor were we able to find a lung-specific genotype associated with macrophage tropism in V3. In all
four subjects in whom predicted X4 genotypes were found in blood, predicted X4 genotypes were also found in lung.
Conclusions: Our results support a picture of continuous migration of HIV-1 between circulating blood and lung tissue, with
perhaps a very limited degree of localized evolution or clonal replication.
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Introduction
HIV-1 infection is associated with a variety of infectious and
non-infectious pulmonary complications, and pulmonary infec-
tions appear to accelerate the progression of HIV-related disease
[1,2,3,4,5,6]. Although pulmonary lymphocytes appear to be the
major reservoir for HIV-1 DNA in the lung [7,8,9], the lung is
distinguished from other organs in having a high percentage of
resident macrophages (alveolar macrophage, AM) [10] as potential
targets of infection and as sites where HIV replication may occur.
Previous studies examining HIV-1 in the lung and blood suggest
that lung viruses contain amino acid signatures associated with
macrophage tropism [11], have higher percentages of monocyto-
tropic viruses [12], are more likely to be CCR5-tropic [13], and
are more homogenous than virus found in blood [11,14]. These
studies all indicate some degree of genetic compartmentalization
between lung and blood as well, though the methods used to
define compartmentalization varied. In contrast, an autopsy study
[15] reported no simple relationship between syncytium-inducing
(SI) and non-syncytium-inducing (NSI) genotypes in the lung from
three subjects, though they also observed phylogenetic clustering
of lung sequences apart from virus in other tissues in two of the
three subjects. Genetic compartmentalization has also been
observed in C2-C3 env sequences from blood and pleural fluid in
four of eight HIV-infected subjects with pleural TB [16].
While these studies generally point to genetic compartmental-
ization between blood and lung, the causes, degree, and extent of
compartmentalization have not been fully resolved. The studies
cited above all sampled a relatively small number of viruses from a
small number of patients, and compartmentalization was not
observed in all subjects, nor was it rigorously defined. Certain key
studies [11,14], moreover, focused on a very limited section of the
viral genome, the V3 loop. In addition, several of these studies
relied on population sequencing, a process that can result in biased
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6949estimates of viral diversity and recognition of only major viral
genotype(s). Finally, there remains the unresolved issue of why
lung viruses should show patterns of compartmentalization
consistent with macrophage tropism when most of viral RNA
and DNA isolated from the lung comes from pulmonary
lymphocytes [8,9].
In this study, we addressed these issues using a more
comprehensive data set: HIV-1 env C2-V5 sequences from lung
and blood from 18 sets of paired blood and lung samples in which
viral sequences were PCR amplified via limiting dilution to avoid
viral template resampling and thus obtain an accurate view of
variant representation, within the context of the ever-present
possibility of biased PCR amplification due to primer selection.
The 18 sets consisted of nine pairs of induced sputa (IS) and blood
samples and nine pairs of bronchoalveolar lavage (BAL) and blood
samples, including four who were sampled before and after
antiretroviral therapy. We applied phylogenetic and bioinformatic
analyses to these sequence data to test the following hypotheses: (i)
Are lung viruses genetically compartmentalized compared to those
in the blood? (ii) Does lung preferentially contain viruses of the R5
phenotype? (iii) Does the lung serve as an archival reservoir for
viral genotypes present earlier in infection? Contrary to previous
reports, which painted a fairly simple picture of viral compart-
mentalization in the lung, we find a mixed pattern in which virus is
compartmentalized in some patients and not compartmentalized
in other patients. In all cases where virus did compartmentalize,
the effects were subtle; i.e., detectable using statistical tests, though
not always immediately obvious from visual inspection of
phylogenetic trees. Attempts to relate compartmentalization to
diversity, divergence, cell tropism, or clinical indicators such as
viral load, CD4+ T cell count, and time infected, did not yield any
significant correlations.
Methods
Study Populations
Paired lung and blood samples were obtained from three
sources: Induced sputum (IS) and bronchoalveolar lavage (BAL)
from HIV-infected subjects collected at the University of
Washington (UW-BAL), and BAL samples collected from four
serially sampled HIV-infected subjects initiating HAART at
Indiana University (IU-BAL) with informed consent using human
subjects protocols approved by both institutions. Under all three
protocols, blood samples were taken within two hours of initiating
IS or BAL. All samples came from HIV+ adults (.18 yrs). The IS
and UW-BAL samples came from patients with no overt evidence
of lung disease. The IU-BAL samples came specifically from
subjects with elevated pulmonary lymphocyte counts who did not
have evidence of serious pulmonary infections. The IU-BAL
patients initiated triple-drug HAART after the initial BAL, and
were lavaged again after 4, 24, and 52 weeks. Treatment
information and other clinical parameters are summarized in
Table 1. The IU-BAL procedures, undertaken in part to address
the effects of HAART on pulmonary lymphocytes, have been
previously described in detail [17].
Processing of blood, induced sputum, and BAL
Blood was collected into BD ACD vacutainer tubes (Becton
Dickinson 364606) for isolation of plasma (PL) and peripheral
blood mononuclear cells (PBMC) by Ficoll density gradient
centrifugation using Lymphocyte Separation Medium (LSM)
(Cappel 50494, Aurora, OH). At UW, PBMC were fractionated
into peripheral blood lymphocytes (PBL) and peripheral blood
monocytes (PBM). For the UW IS subjects, monocytes were
isolated from PBL using monocyte adherence as described [18].
For the UW BAL subjects, monocytes were isolated from PBL
using MACS CD14 microbeads and MACS LS column according
to the manufacturer’s instructions (Miltenyi Biotec, cat# 130-050-
2010).
Induced sputum (IS) were obtained and processed as detailed
(Frenkel et al., 2009 submitted). Due to interfering squamous
epithelial cells (5–75% of IS cells) in most sputum samples, we
fractionated the IS-derived cells using LSM. Alveolar macrophag-
es (AM) and lymphocytes were isolated in the LSM band, and
squamous epithelial cells, red blood cells, and dead cells were
found in the LSM pellet. We did not attempt isolation of AM from
lymphocytes due to low live cell recovery from most induced
sputum samples. At all steps in the process small aliquots were
taken and cytospins performed for determination of IS cell
differential.
Bronchoalveolar lavage (BAL) was performed by advancing a
flexible bronchoscope into subsegmental bronchi in the right and
left lungs at both UW and IU. Five 30 ml aliquots of sterile 0.9%
saline was injected into each subsegment and gently suctioned into
a trap [19]. The recovered BAL fluid was passed through a nylon
filter to remove clumps and mucus then centrifuged at 300 g for
10 minutes to obtain BAL fluid supernatant (BALF) and BAL cells
(BALC). At UW, AM in the BALC were enriched first by
fractionation on LSM: AM and lymphocytes were isolated in the
band; red blood cells and dead cells were in the pellet. CD3+
lymphocytes were removed from the LSM banded BALC using
MACS CD3 microbeads and MACS LC column according to the
manufacturer’s instructions (Miltenyi Biotec, cat#130-050-101).
These are referred to as BALC*. One exception to the above
process was BALC from UW-BAL10. In this case BALC were
fractionated on 46% Percoll gradients (GE Healthcare, cat#
17089102) prior to CD3+ lymphocyte removal (BALC**). Half of
these BALC** were adhered to plastic for 2 hours, rinsed three
times with PBS to remove any non-adherent cells, and adherent
cells detached with ice-cold PBS-EDTA (BALC***). At all steps in
the process small aliquots were taken and cytospins performed for
determination of BAL cell differential. BAL fluid supernatant,
plasma, and cell pellets were frozen at 280uC for later analysis.
Although the BAL samples were clear on visual inspection,
small amounts of blood were detected in the pellets from UW-
BAL5 and UW-BAL8. While differential analysis of cytospins
showed that the BALC* samples from UW-BAL5 and UW-BAL8
were free of blood lymphocytes, the BALF from these subjects
could contain a small amount of viral RNA from plasma.
PCR and sequencing procedures
Viral RNA was isolated from plasma (PL) and from the BAL
fluid of two subjects (BAL05 and BAL08–the two subjects from
which we observed a small amount of blood in the BAL pellets)
and converted to cDNA as described [20]. Genomic DNA from all
other tissues was isolated and purified by the Tissue Protocol of
QIAampHDNA Mini Kit (Qiagen Inc., Valencia, California).
DNA and cDNA isolated from patient samples were used to
generate PCR products and HIV-1 env gp120 sequences of regions
C2 through V5 (HXB2 coordinates 6582–7700).
PCR was performed using AmpliTaqH DNA polymerase with
GeneAmpH 10X PCR Buffer II and MgCl2 solution (Applied
Biosystems, Foster City, California), balanced dNTPs at 200 mM
(GE Healthcare Life Sciences, Buckinghamshire, U.K.), with outer
primers in a first round PCR at 0.3 mM (Invitrogen, Carlsbad,
California) -PE1 (59-TAGAAAGAG CAGAAGACAGTGG-
CAATGA-39) and PE2 (59-GCCTGGAGCTGTTTGATGCCC
CA-39), and inner primers (in a second round PCR) ED5 (59-
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CCTTGGTGGGTGCTACTCCTAATGGTTCA-39). The PCR
conditions used for the first round PCR were an initial 94uC
denaturation of 2 minutes, followed by 35 cycles of 94uC for 15
seconds, 55uC for 30 seconds, 72uC for 2 min, concluding with a
72uC extension for 7 min. Conditions used for the second round
PCR were identical, except for a cycled extension step of 90 seconds
at 72uC. To avoid template re-sampling, we performed limiting
dilution PCR, calculating the sample volume necessary to equal one
theoretical copy/PCR reaction with the ‘‘Quality’’ program (http://
ubik.microbiol.washington.edu/computing/quality/jquality.htm)
[21],
Independent PCR products were separately cloned using
Invitrogen TOPO TAH Cloning kits (Invitrogen Corporation,
Carlsbad, California), with each transformation cultured on LB
agar, in separate wells of 24-well plates. To prevent template
resampling, single colonies were picked from each well and
cultured in LB broth overnight, with plasmids isolated using
QIAprep spin miniprep kits (QIAGEN Inc.) according to the
manufacturer’s instructions.
Sequencing was performed by the University of Washington
Department of Biochemistry DNA Sequencing Facility (http://
depts.washington.edu/biowww/dna/index.html). Before initiating
more detailed phylogenetic analyses, we compared sequences
against the HIV-1 database using ViroBLAST [22] and grouped
them into phylogenetic trees using a neighbor-joining algorithm.
Sequences that closely matched viruses in the database or that
clustered with sequences from another patient were flagged as
possible contaminants.
Phylogenetic Analysis
Nucleotide sequences were aligned with ClustalW version 1.4
[23] and the alignment refined using MacClade v4.08 software
[24]. Version 3.06 of Modeltest [25] was used in conjunction with
PAUP* 4.0 [26] to estimate the best evolutionary model for the
construction of each maximum likelihood (ML) tree using the
Akaike Information Criterion [27]. Each subject alignment was
carefully examined for regions of highly variable, ambiguous
alignment, in which a preponderance of indels and repeats
occurred, making a probable alignment difficult. These regions
were excluded on a by-patient basis, while retaining as much of the
alignment as possible. PAUP* was used to calculate each patient
ML tree with its optimal model from Modeltest in a heuristic
search with a neighbor-joining start and SPR branch swapping.
Three subtype B reference sequences from the LANL database
(accession numbers M63929, U63632, and U95413) were used as
outgroup sequences to root the trees. Diversity distances were
calculated as the total pair-wise distances in PAUP* between all
sequences within each compartment, under the same best-
estimated model defined by Modeltest to calculate the tree.
Divergence was calculated as the pairwise distance from each
sequence to the most recent common ancestor, which is the
sequence estimated at the basal root node of the tree node where
the outgroup sequences join the ingroup sequences. Statistical
comparisons between tissue pairs in each individual were
calculated using the Wilcoxon Rank Sums test. Intra- and inter-
subject statistical comparisons of diversity between tissue pairs for
pooled data were calculated using a statistical that accounts for the
inherent dependency of sequences on one another [28] (http://
www.scharp.org/users/adecamp/diverstest/runtests.php).
VESPA analysis and V3 frequency chart
Aligned protein sequences of lung and blood tissue variants were
analyzed using Viral Epidemiology Signature Pattern Analysis
(VESPA) [29] (http://www.hiv.lanl.gov/content/sequence/
VESPA/vespa.html) for each possible pair of tissues. Graphical
representations of the pooled lung and pooled blood V3 loops were
constructed in WebLogo 3 [30,31] (http://weblogo.berkeley.
edu/).
Co-receptor Prediction
CCR5 or CXCR4 coreceptor usage was predicted from the
amino acid sequence of the V3 loop region using the subtype-B-
specific Web PSSM genotypic interpretation algorithm [32]
(http://ubik.microbiol.washington.edu/computing/pssm/index.
html). Comparative statistics were done using the Fisher’s Exact
Test.
Statistical Tests for Compartmentalization
Five methods were used to determine virologic compartmental-
ization between every tissue pair within each subject [33,34,35,36].
Four of the tests were based on the topology of the phylogenetic
trees, while one test relied on genetic distances between sequences.
We analyzed each tissue pair separately. The four phylogenetically-
derived methods for detecting compartmentalization were: 1)
Slatkin-Maddison (SM), which determines the minimum number
of migration events between two populations based on the tree
topology; 2) Simmonds Association Index (AI), which assesses the
degree of population structure, weighting the contribution of each
internal node based on how deep it is in the tree, and; Correlation
Coefficients, either by 3) length of branches ‘‘r’’ or by 4) number of
branches ‘‘r
b.’’ The correlation coefficients tests look at any two
sequences in a tree to determine whether or not they originate from
the same compartment by examining tree structure and distances,
i.e., the cumulative genetic distances between sequences (the length
of branches) (r), or the number of tree branches separating the
sequences (r
b). The distance-based method used was the Nearest
Neighbor statistic (Snn), a measure of how often the ‘‘nearest
neighbor’’ (in sequence space) sequences are from the same locality
in geographic space. Statistics and compartmentalization tests were
implemented in HyPhy as described [37].
Since these methods use different algorithms to measure whether
or not there is evidence of genetic compartmentalization between
two tissues, they each have various strengths and weaknesses. The
SM method is entirely dependent on the structure of the tree,
including the number of internal and external branchings as
‘‘migrationstep’’counts; however, branchlengths arenot takeninto
account. The AI method also does not take branch lengths into
account, and like the SM, is dependent on the structure of the tree,
but adds a degree of complexity by weighting the contributions of
thenodesbetweenanygiventwosequencesbasedonwheretheyare
located in the tree (i.e. how deep in the tree they are). The
correlation coefficients use yet a different equation to assess
sequence relatedness; the r test actually takes into account branch
lengths and the evolutionary paths between sequences, while the r
b
examines the number of branches between sequences, and so takes
intoaccountpopulationstructureinadifferentmannerthantheSM
and AI tests. While the tree-based methods, as a whole, are
dependent on the structure of the tree to varying degrees and are
appealing since we are often able to confirm the results when we
examine the tree subjectively, the distance-based test is a good
indicator of genetic similarity between sequences within a tissue,
independent of evolutionary path, and is important to include in the
case of a phylogenetic tree being difficult to resolve or having very
short branch lengths. While some previous studies have simply
examinedclusteringofspecifictissuesequencesinphylogenetictrees
by eye to classify compartmentalization, sometimes the degree of
clustering is not always obvious in trees in which there are multiple
HIV Lung Compartmentalization
PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e6949small clusters, or in which some tissue sequences cluster together
and others are scattered throughout the tree. It is important to have
a mathematical method to classify such trees.
We also screened each tissue pair alignment for recombination,
which could potentially obscure detection of compartmentaliza-
tion. We used a genetic algorithm approach [38] implemented in
DataMonkey (http://www.datamonkey.org/GARD/) to detect
recombination breakpoints. Each non-recombinant fragment
defined by these breakpoints was then analyzed separately for
compartmentalization using the previous methods.
Associations between compartmentalization and various clinical
parameters including diversity, divergence, viral load, and CD4+
T cell count were assessed using Wilcoxon Rank Sums tests, in
which subjects exhibiting evidence of compartmentalization
between lung and blood were compared to those who did not
exhibit evidence of compartmentalization.
We note that none of the statistical tests reported here adjusted for
multiple comparisons. While it is customary to adjust p-values for
multiple comparisons when making positive claims, our use of
uncorrected p-values is conservative with respect to the negative con-
clusions in this study (i.e., that compartmentalization was minimal).
Potential N-Linked glycosylation sites (PNGS) and amino
acid length
N-linked glycosylation sites were predicted using N-glycosite
[39] (http://www.hiv.lanl.gov/content/hiv-db/GLYCOSITE/
glycosite.html). The number of amino acids between HXB2
gp160 position 267 and 471 (C2 to V5) were tallied for each
sequence. Statistical comparisons between tissue pairs within each
subject were calculated using the Wilcoxon Rank Sums test.
Nucleotide sequence accession numbers
All sequences were submitted to GenBank and assigned accession
numbers GQ444145-GQ444329 and GQ456230-GQ456929.
Results
HIV-1 env V3 loops from lung and blood samples are
indistinguishable
Previous studies [11,14] claimed that V3 loops from lung
samples were more homogeneous in the C-terminal region of the
V3 loop but were more diverged overall than blood viruses. To
test this finding, we calculated divergence and diversity of full
length and C-terminal-region of V3, in lung and blood tissue from
all 18 subjects. While there were a few instances in which lung
diversity was significantly different from one or more blood tissues
within a subject, it was the exception rather than the rule, and
overall, lung (from either IS or BAL) was not more or less
homogeneous in the whole V3 or in the C-terminal region than
any blood tissue. The same held true for the divergence of V3
from the subject’s inferred MRCA in the lung and blood (results
not shown).
One of these previous studies [11] also claimed that lung BAL
contained a highly conserved, negatively charged amino acid motif
that may be associated with macrophage tropism [40], while V3
loops in blood were less likely to contain this motif, which was
defined as Y-X-T-X-X-X-I-G-D [11] or Y-X-T-X-E-X-I-X-D-I
[40] from residues 21 to 29 in the V3 loop. We identified these
motifs in both our lung and blood samples in very similar
frequencies, regardless of whether the samples were from IS or
from confirmed purified BAL (Figure S1). Also, no signature sites
in IS or BAL were identified throughout the V3 loop by VESPA, a
program designed to detect signature amino acid sequences (see
Methods), when compared to any blood tissue (results not shown).
X4 genotypes are as likely to be found in lung as in blood
Previous studies found that HIV-1 in the lung was more likely to
be macrophage- [11] or CCR5-tropic [13] than blood, reflecting
different potential target cell pools in each tissue. We applied the
WebPSSM algorithm [32] to V3 loops to predict virus coreceptor
usage. In all subjects in whom X4 genotypes were detected in
blood (3/9 IS subjects and 1/9 BAL samples), X4 viruses were
detected in lung samples as well (Figure 1). No single tissue
contained a significantly different frequency of X4 viruses than any
other tissue. Thus, we saw no evidence that lung-derived virus is
enriched for R5 variants relative to blood.
Statistical evidence for a modest degree of
compartmentalization between blood and lung HIV-1
env sequences
We examined HIV-1 C2-V5 sequences from multiple tissues to
assess whether or not there was a restriction of HIV-1 gene flow
Figure 1. HIV-1 co-receptor usage predictions. X4 viruses were predicted in (A) four IS subjects and (B) on IU subject (IU-BAL4) in multiple
timepoints via the WebPSSM. There were no significant differences in frequency of X4 detection between tissues within any subject (Fisher’s Exact
Test).
doi:10.1371/journal.pone.0006949.g001
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determine whether or not there was compartmentalization
between any two tissues; four of the methods were phylogenetic
tree-based (SM, AI, r, and r
b) (Figures 2 and 3) while one method
(Snn) used a genetic distance-based approach, in which distances
were derived from nucleotide alignments. Since each method has
specific strengths and weaknesses and no gold standard has as yet
been accepted, and given the frequency with which these methods
frequently disagree [37], for each tissue pair we simply took a
majority consensus approach and classified the pair as exhibiting
compartmentalization if at least three of the five tests indicated
significant evidence for compartmentalization, as determined by
the permutation tests employed for each method. We also
screened every tissue-pair alignment for recombination with
GARD, and re-analyzed the non-recombinatory fragments
defined by GARD for compartmentalization in the same manner
as before.
Under this design, we found evidence of compartmentalization
between lung and at least one blood tissue in six of the nine IS
subjects, and in three of the five UW BAL subjects (Table 2). We
analyzed each time-point of the IU BAL subjects separately, and
did not find evidence of compartmentalization until we examined
the non-recombinatory fragments defined by GARD, at which
point we found evidence for compartmentalization in the first
time-point only of one subject. Recombination breakpoints were
found in almost every tissue-pair alignment; however, except in the
aforementioned IU BAL case, compartmentalization results were
not different from those calculated from the whole alignment
(results not shown). We were not able to obtain both IS and BAL
samples from the same subject to determine the extent of sampling
differences between these two types of tissues, nor were we able to
obtain two separate samples within a small window of time (hours
or days) from any one subject to examine potential geographic
sampling bias effects. We acknowledge that a potentially broader
sample was obtained from the BAL, as the IS samples are from the
airway and generally had little virus, while the BAL samples
encompass an entire lobe of the lung and are likely to come in
contact with the epithelial lining fluid as well. However, according
to a Fisher’s Exact Test, there was not a significant difference in
the amount of compartmentalization we saw in the IS subjects (six
of nine compartmentalized) vs. the BAL subjects (four of nine
compartmentalized).
Whether or not a subject was determined to have genetic
compartmentalization between lung and at least one blood tissue
was not related to viral load, CD4 count, or viral diversity or
divergence in blood (p.0.05 for all comparisons). Nor was
evidence for compartmentalization related to the percent lympho-
cytes in BAL samples; of the two subjects in which 99% or more of
the cells were alveolar macrophages, we found evidence of
compartmentalization between lung and blood in one of them
but not in the other.
We noted that many of the examples of compartmentalization
in Table 2 involved comparisons between DNA (PBM, PBL,
PBMC, IS, and BALC) and RNA (PL) sequences. Of the 13
subjects from whom we obtained plasma sequences, we found
evidence for compartmentalization between plasma (PL) and lung
in 6 subjects. In contrast, we found compartmentalization between
PBL and lung in 3 out of 13 subjects for whom we obtained PBL
Figure 2. Phylogenetic trees of IS subjects. All trees are maximum likelihood trees calculated under the best-estimated model as determined by
ModelTest.
doi:10.1371/journal.pone.0006949.g002
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we obtained PBM samples; and between PBMC and lung in 1 out
of 6 subjects for whom we obtained PBMC samples. When we
examined compartmentalization outside of the lung (between any
two blood tissue pairs, i.e., PBMC, PBL, PBM, PL), we found
evidence for compartmentalization between any blood tissue pair
in seven comparisons from five subjects, and in all seven cases, PL
was one of the blood tissues involved. In no case did we find
compartmentalization between just the blood tissues PBL and
PBM.
Table 2 also summarizes tests involving RNA from BALF, but
these tests are clouded by the fact that there was a trace amount of
blood in the two BAL samples from which we detected viral RNA
in BALF. Given the plasma viral loads in these subjects, it should
be possible to detect viral RNA in BALF even assuming a 100-fold
dilution of plasma into BALF. Indeed, the fact that plasma and
BALC, but not plasma and BALF, were compartmentalized in
UW-BAL8, is consistent with the hypothesis that the RNA in this
BALF sample came from plasma.
Presence of Nearly Identical Sequences in BAL Samples
In two subjects, UW-BAL6 and IU-BAL1 (week 52 timepoint
only; there was no matching PBMC, so no compartmentalization
tests were done), we noted a large number of nearly identical
sequences in BAL, which is something rarely, if ever, seen in blood
samples in patients in chronic infection who are not on
antiretroviral therapy. We observed this phenomenon in the IU-
BAL subject well after the initiation of therapy; we do not know for
certain how long this subject had been infected, though it was for
at least one year. The UW subject had been on antiretroviral
therapy only briefly, was not currently on therapy at the time of
sampling, and had been infected for at least five years. Twenty out
of 22 lung sequences were identical or nearly identical to one
another in this subject, while the blood sequences were not
homogeneous (Figure 3B).
The Diversity And Divergence of HIV-1 env Sequences
from Lung and Blood Do not Differ Significantly
To assess whether viruses in lung evolve differentially from those
in blood, we used the nucleotide alignments to calculate two
statistics: (1) divergence, which is the genetic distance between
nucleotide sequences from blood and lung to the inferred MRCA
(Figure 4); and (2) the mean pairwise nucleotide diversity of viruses
in blood and lung samples (Figure S2). In samples from subjects
not undergoing anti-retroviral therapy, we observed no consistent
trends wherein samples from lung were either more or less
divergent or diverse compared to viruses from blood samples. This
lack of consistent trend persisted whether lung virus came from IS
or BAL cells, whether BAL cells contained .99% AM, whether
blood virus came from PBL, PBM, or plasma, or whether the
patient had started antiretroviral therapy. Virus from lung was
seldom more or less divergent than blood within subjects; lung was
significantly more diverged than one blood tissue in two subjects,
and significantly less diverged in four subjects, while there was no
difference between lung divergence and any blood tissue
divergence when divergence values from all subjects were pooled.
Likewise, lung was significantly less diverse than virus from a blood
compartment in two subjects, and as mentioned above, in one of
Figure 3. Phylogenetic trees of BAL subjects. All trees are maximum likelihood trees calculated under the best-estimated model as determined
by ModelTest. (A) IU-BAL (Indiana University bronchoalveolar lavage) subjects; (B) UW-BAL (University of Washington bronchoalveolar lavage)
subjects. ** and ***: alternative methods of AM enrichment in subject UW-BAL10, see methods.
doi:10.1371/journal.pone.0006949.g003
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identical. Lung was more diverse than at least one blood tissue in
five subjects. Overall, when distances from all subjects were
pooled, there was no significant difference in diversity between any
two tissues.
One subject, IU-BAL3, had one lung sequence that was much
more diverged from the MRCA than any other sequence from
that subject and was also very diverse compared to the other lung
sequences. The distance from this unusual sequence to the MRCA
was .0.1 substitutions/site, while the distances to the MRCA of
the other sequences were between 0.005 and 0.048 substitutions/
site. The alignment was double-checked and a neighbor-joining
tree was made containing .200 subtype B reference sequences
plus all of the subject sequences, and still the highly diverged
sequence grouped closely with the subject’s own sequences, and
thus there was no evidence that it derived from superinfection
from a second source of infection. The sequence was not deemed
to be hypermutated, nor did it contain any stop codons. Thus,
despite the large distance between it and other sequences, it was
not removed or considered to be a contaminant.
HIV-1 C2-V5 Sequences from Lung and Blood have
Similar Numbers of Potential N-Linked Glycosylation Sites
and Are the Same Length
The number of Potential N-Linked Glycosylation Sites (PNGS)
and sequence length have been examined in the context of HIV-1
tissue compartmentalization [14,41,42,43], with the rationale that
the neutralizing antibody response, which influences PNG patterns
Table 2. Results of compartmentalization tests.
Subject
Tissues from which we
obtained sequences
Lung vs. blood tissue pairs
in which compartmenta-
lization
1 was detected
Blood vs. blood tissue pairs
in which compartmenta-
lization was detected SM Snn rb r AI
IS-8247 IS, PBL, PBM, PL Lung vs PL –
* *** *
IS-8835 IS, PBL, PBM, PL – – NS
IS-8837 IS, PBL, PBM, PL Lung vs PBL
** * ** **
Lung vs PL
* *** *
PBL vs PL
*** *
IS-8838 IS, PBL, PL Lung vs PBL –
** *
IS-8840 IS, PBL, PBM, PL Lung vs PL
*** *** ** **
PBL vs PL
** * *
PBM vs PL
*** * * *
IS-8886 IS, PBL, PBM, PL – – NS
IS-8948 IS, PBMC, PL – – NS
IS-8992 IS, PBMC, PL Lung vs PL
*** *** ** **
PBMC vs PL
** ** ** **
IS-9000 IS, PBM, PL Lung vs PBM –
** * *
IU-BAL1 BALC
3, PBMC – – NS
IU-BAL2 BALC
3, PBMC – – NS
IU-BAL3 BALC
3, PBMC – – NS
IU-BAL4 BALC
3, PBMC Lung vs PBMC –
** * *
UW-BAL5 BALC
4, BALF
2, PBL, PBM, PL – – NS
UW-BAL6 BALC
4, PBL, PL Lung vs PBL –
*** *** ** ** *
Lung vs PL
*** *** ** ** **
UW-BAL8 BALC
4, BALF, PBL, PBM, PL Lung (BALC
4)v sP L
** ** * **
PBM vs PL
*** * *
UW-BAL9 BALC
4, PBL, PBM, PL Lung vs PBL
** * * * * *
PBL vs PL
** * * * * *
PBM vs PL
** * * *
UW-BAL10 BALC
5, BALC
6, PBL, PBM – – NS
Only tissue pairs that were designated as compartmentalized with respect to one another (defined as having significant results in 3/5 tests) are listed.
1Compartmentalization was designated when significance was detected in at least 3 of the 5 statistical tests.
2BALF: HIV-RNA from bronchoalveolar lavage fluid.
3BAL cells not enriched from AM (BALC in Table 1).
4BAL cells enriched by LSM and CD3-depleted (BALC* in Table 1).
5BAL cells fractionated on 46% Percoll gradients prior to CD3-depletion (BALC** in Table 1).
6BAL cells treated as in 5 above, but further enriched for AM by adherence (BALC*** in Table 1).
*p-value=0.01–0.05.
**p-value =0.001–0.009.
***p-value ,0.001 (blank = p-value .0.05).
NS Data not shown, no tissue pair met the criteria for compartmentalization.
doi:10.1371/journal.pone.0006949.t002
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ronments. A PNG, defined as any amino acid sequon N-X-T or
N-X-S (unless X=Proline), was calculated for each sequence from
HXB2 position 267 to 471 (part of C2 through end of V5). In only
a few cases were there differences in the numbers of PNGS
between compartments (Figure S3); in the IS cohort, subject 8835
and 8837 sequences from lung had significantly more PNGS than
were found in PBL; in subject 8992, sequences from lung had
fewer PNGS than did sequences from PL. In the UW BAL cohort,
subject BAL5 sequences from the lung had significantly fewer
PNGS than sequences from PL, PBL, and PBM. In the IU-BAL
cohort, subject BAL4 sequences from lung had significantly more
PNGS than PBMC in both the week 0 timepoint and the week 4
timepoint. When subjects were pooled, there was no significant
difference in PNGS between any two tissues. The lengths of
sequences from each compartment were also very similar, with
very little intra-patient variation and no inter-patient variation
between compartments (data not shown).
No Evidence for Directional Viral Gene Flow between
Blood and Lung
Given that HIV is not always detected in lung samples and that
patients are generally infected via genital fluids and contaminated
blood (i.e., by non-aerosol routes), blood should be colonized before
lung. To address whether this presumed order of infection affects
viralevolution,weexaminedthe phylogenetictrees(Figures2 and 3)
for evidence that blood sequences rooted closer to the MRCA than
lung sequences. Visual inspection of the phylogenetic trees and the
calculated divergence values (Figure 4) suggested that PBM/PBMC
viruses could have been ancestral to IS viruses in donors 8835 and
8992, which was supported by 100% bootstrap values at the
ancestral node when sampling with replacement. However, for the
remaining IS and BAL samples, there was no evidence for any
particular compartment being ancestral to any other, with the
minimum genetic divergence in blood and lung tissues being
roughly the same and with the basal genotype being roughly equally
spread out between the various blood and lung tissues.
Discussion
Restrictions on the ability of virus to migrate freely between
different cells, tissues, and organs can have a profound effect on
viral diversity and divergence, the ability of virus to replicate (or
persist in a dormant form) during antiretroviral therapy, and the
ability of virus to acquire new cell tropisms. Previous studies
[11,14] have suggested that the lung is a privileged site in which
HIV-1 evolves quickly towards a homogeneous phenotype. In this
study, we have sought to test these predictions by sequencing virus
from a large number of paired samples from blood and lung.
While we did find evidence for compartmentalization between
lung and at least one blood tissue in ten of 18 subjects,
Figure 4. Divergence from MRCA. Distances were calculated under maximum likelihood parameters established under ModelTest. Pair
comparisons were made using the Wilcoxon Rank Sums test. (A) IS subjects; (B) IU-BAL subjects; (C) UW-BAL subjects. For pair comparisons: *p-value
=0.01–0.05; **p-value=0.001–0.009; ***p-value,0.001.
doi:10.1371/journal.pone.0006949.g004
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general, HIV-1 variants from the blood and lung were more often
intermixed than segregated; in most of the subjects evidence of
compartmentalization was not apparent from visual inspection of
the phylogenetic trees. Furthermore, we saw no evidence that lung
samples contained signature sites in the V3 region or an excess of
CCR5-tropic viruses or archival genotypes. The limited evidence
of compartmentalization was observed in HIV-1 patients with
(Indiana cohort) or without (Seattle cohort) evidence of elevated
lung lymphocyte counts, and was not notably influenced by
whether virus came from induced sputum, BAL fluid, BAL cells,
or BAL cell samples enriched for AM.
The limited amount of compartmentalization that we did
observe seemed to be related to two factors. The first was the
unexpected presence of identical or nearly identical sequences in
some of the BAL samples. Although identical sequences have been
observed in samples from patients on HAART [46,47], it is rare to
find identical env sequences from blood samples from patients not
on therapy. In the case of UW-BAL-06, 20 of the 22 BAL
sequences were identical or nearly identical, despite avoiding
resampling and contamination. Many other subjects had from two
to six identical or nearly identical lung sequences. The presence of
nearly identical sequences contributed substantially to statistical
evidence of compartmentalization in these subjects, and suggests
that compartmentalization could be due, in part, to small,
localized clonal expansions as opposed to restrictions in migration
[46,47].
The second factor underlying compartmentalization in our
study was a correlation between compartmentalization and plasma
RNA. Detecting differences between any proviral tissue and
plasma is not surprising, as virus found in plasma was sequenced
from HIV-1 RNA, while the virus found in lung tissue, PBL, PBM,
and PBMC were sequenced from viral DNA. It has been shown
that virus in plasma may reflect a more contemporary quasis-
pecies, in which the cellular origins of the plasma virus are most
likely from an actively replicating cell population which turns over
very quickly (perhaps from a small subset of the PBMC pool),
while cell-associated DNA may harbor archival species derived
from latently infected, long-lived cells within the PBMC pool
[48,49]. These differences in turnover rate could be substantial
enough to look like compartmentalization, and could therefore be
contributing to the amount of blood/lung compartmentalization
detected.
By contrast, we did not find evidence that compartmentalization
was related to selection for specific viral variants. If antibody
escape mutants were driving compartmentalization between lung
and blood we might expect to see differing PNGS and length
profiles, as HIV-1 variants in the lung would have access to
differing cellular compositions and antibody profiles, and would
adapt accordingly. Our finding of both X4 and R5 viruses in lung
are consistent with previous studies [15], which found both SI and
NSI genotypes in a variety of tissues, including lung (though they
also reported tissue-specific viral variants in brain, lung, and testis).
Lung tissue is distinguished from other tissues in having a very
high proportion of macrophages, and it has been proposed that
selection for infection of macrophages might create distinguishing
genetic features of lung virus compared to blood virus [14]. Studies
have shown that AM, which are the frontline of defense against
pathogens in the lung, can be productively infected by HIV-1
[9,14], though potentially at low levels [50]. The presence of AM
as local targets for HIV-1 infection, along with an environment
containing a variety of antimicrobial proteins and peptides that
comprise the pulmonary innate immune response [51], could
theoretically drive selection for specialized HIV-1 quasispecies
within the lung. The fact that HIV-infected AM can survive and
produce virus for several weeks in vitro further suggests that the
lung could contain an excess of archival genotypes (viruses that
genetically resemble viruses found in lymphocytes during earlier
phases of infection).
However, the above theoretical reasons for expecting that the
lung could be a reservoir for distinct viral populations need to be
balanced against findings that the frequency of detecting HIV-1 in
alveolar lymphocytes is much higher than the frequency of
detecting HIV-1 in AM in individuals not undergoing ART [8,9],
which could indicate trafficking of lymphocytes from the
peripheral blood to the lung [52]. Furthermore, CD4+ T cells in
BAL are infected at similar frequencies to CD4+ T cells found in
blood in subjects with chronic infection, and are not massively
depleted, as has been found in the GI tract [8]. Also, it is known
that both cell-free virions and HIV-infected lymphocytes are
capable of trafficking between blood and lung [53,54], and
detection of HIV-1 in AM is more likely in patients with more
advanced disease and lower peripheral blood CD4+ T cell counts
[9].
HIV-1 variants in lung have previously been found to be similar
to virus found in lymphoid tissue in some subjects [13,36]. The
lymphatic and circulatory systems continually circulate cells
throughout the body, and could be vehicles for free virus and/or
HIV-infected T-cells trafficked between lymph nodes and the
lung. These processes may be accelerated as T lymphocytes are
trafficked into the lung in response to inflammatory reactions, and
indeed, HIV-1 infection induces T-cell alveolitis in the lung during
early infection [55,56]. While the relatively small subset of CD4+
T cells found in the lung are infected in high frequencies, it has
been reported that CD8+ T cells, present in high quantities during
HIV-induced alveolitis, can also be infected [57]. High densities of
CD4+ T-cells or CD8+ T-cells may create microenvironments for
rapid spread of viruses between lymphocytes and alveolar
macrophages. Whatever the mechanism, our results support a
picture of continuous communication between circulating blood
and lung tissue, with a limited degree of localized evolution or
clonal replication.
We cannot exclude the possibility that the lung could serve as a
reservoir for HIV-1 in some cases. For instance, suppression of
viral load (such as in subjects on effective therapy) may allow for
minority cell populations within the lung to sustain populations of
viruses that are distinct from those found in blood. Indeed, it has
been shown in pediatric subjects under mostly effective ART
(,50 copies/mL with blips ,400 copies/mL) that virus in
induced sputum evolves more drug resistance mutations than
virus obtained from blood, and also that viral env gene sequences in
induced sputum is more diverged than virus in blood [58]. This
suggests that viral suppression may enable detection of low-level
replication in the lung in the absence of widespread dissemination
of virus from blood, and that effective suppression of virus could
allow for restriction of migration and be a complicating factor in
treatment. However, we did not see the same pattern in our study;
two IS subjects had viral load ,50 (IS-8247 and IS-8886) and one
IS subject had viral load of 52 copies/mL (IS-9000) due to
effective ART (Table 1), and divergence did not differ significantly
between lung and blood in any of these subjects (Figure 4). This
suggests the increased divergence in lung described here could be a
phenomenon associated with early successful treatment and
perhaps limited to pediatric subjects, though we acknowledge we
did not sample enough subjects on effective ART to investigate
this issue thoroughly.
In summary, the extensive intermingling of virus from multiple
blood tissues with virus from the lung, the lack of a macrophage-
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lung macrophages), and evidence for X4 viruses in both blood and
lung, are consistent with a model in which virus in the blood and
lung are frequently exchanged. This is an optimistic result for
patient treatment, since the presence of genotypically distinct
viruses in different tissues complicates efforts to understand disease
progression and optimize initial antiretroviral drug regimens.
Supporting Information
Figure S1 Inter-subject frequencies of amino acid variants at
each site in V3 in lung and blood. Sequences were pooled from all
subjects. Plots generated from data within each cohort separately
(IS and BAL) or by specific blood tissue (PL, PBM, or PBL) also
did not show significant differences between lung and blood. Sites
21, 23, 25, and 27–28 have been associated with macrophage
tropism in previous studies [5,33].
Found at: doi:10.1371/journal.pone.0006949.s001 (1.92 MB TIF)
Figure S2 Pairwise diversity. Distances were calculated under
maximum likelihood parameters established under ModelTest.
Pair comparisons were made using a pooled median diversity test
[21]. (A) IS subjects; (B) IU-BAL subjects; (C) UW-BAL subjects.
For pair comparisons: *p-value =0.01–0.05; **p-value =0.001–
0.009; ***p-value ,0.001.
Found at: doi:10.1371/journal.pone.0006949.s002 (4.00 MB TIF)
Figure S3 Potential N-Linked Glycosylation sites. The number
of N-X-T and N-X-S (with X not equal to P) sequons was counted
in each C2 to V5 amino acid sequence. Pair comparisons were
made using the Wilcoxon Rank Sums test. (A) IS subjects; (B) IU-
BAL subjects; (C) UW-BAL subjects. For pair comparisons: *p-
value =0.01–0.05; **p-value =0.001–0.009; ***p-value ,0.001.
Found at: doi:10.1371/journal.pone.0006949.s003 (3.77 MB TIF)
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